23 results
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
a 3-point improvement in mADL11
14 Essential3: An innovative Phase 3 program that optimizes all aspects of study conduct Single Recruiting Expert
8-K
EX-3.1
ofly0wnhb9eul228l
7 Jan 22
Amendments to Articles of Incorporation or Bylaws
4:09pm
424B4
innxvggc0q
14 May 21
Prospectus supplement with pricing info
4:34pm
DEF 14A
yd1gc4 y8nb1mumf4nk
29 Apr 21
Definitive proxy
4:04pm
10-K
upmb2xau0fp1vt0l1e79
17 Mar 21
Annual report
8:33am
8-K
EX-3.2
xzqpqu1xbzter0
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:20pm
424B4
8ttfi kkh7
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1
EX-10.16
m1imltuek0wc3z0425wv
25 Sep 20
IPO registration
5:19pm
S-1
EX-10.15
dxhxewyezumxob593
25 Sep 20
IPO registration
5:19pm
S-1
sqpl fdtldc3ghhy1r
25 Sep 20
IPO registration
5:19pm
S-1
EX-3.4
ckv kbwh66xxdbaj
25 Sep 20
IPO registration
5:19pm
DRS/A
6u64o77i hoo
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.17
eeg9iys0wuztqx5h
28 Aug 20
Draft registration statement (amended)
12:00am